EnBio Holdings, Inc (TYO:6092)
Japan · Delayed Price · Currency is JPY 819.00
-6.00 (-0.73%)
Sep 10, 2026, 11:05 AM JST
EnBio Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 13,033 | 12,630 | 10,668 | 9,575 | 8,120 | 8,987 | |
Revenue Growth | 28.92% | 18.39% | 11.42% | 17.92% | -9.65% | 31.39% |
Cost of Revenue | 9,017 | 8,942 | 8,014 | 7,092 | 5,355 | 6,562 |
Gross Profit | 4,016 | 3,688 | 2,654 | 2,483 | 2,765 | 2,425 |
Selling, General & Admin | 2,108 | 2,069 | 1,814 | 1,668 | 1,407 | 1,196 |
Operating Expenses | 2,072 | 2,069 | 1,806 | 1,667 | 1,407 | 1,181 |
Operating Income | 1,944 | 1,619 | 848 | 816 | 1,358 | 1,244 |
Interest Expense | -188 | -179 | -141 | -114 | -124 | -123 |
Interest & Investment Income | 49 | 60 | 60 | 45 | 36 | 25 |
Currency Exchange Gain (Loss) | 197 | 100 | -27 | 186 | 65 | 80 |
Other Non Operating Income (Expenses) | -2 | -2 | -39 | 133 | 8 | -30 |
EBT Excluding Unusual Items | 2,000 | 1,598 | 701 | 1,066 | 1,343 | 1,196 |
Gain (Loss) on Sale of Investments | 238 | 238 | - | - | - | - |
Gain (Loss) on Sale of Assets | -919 | - | - | - | - | -2 |
Asset Writedown | -1 | -1 | -9 | -12 | -110 | -95 |
Other Unusual Items | - | -920 | 9 | 10 | - | -1 |
Pretax Income | 1,323 | 915 | 701 | 1,064 | 1,233 | 1,098 |
Income Tax Expense | 783 | 663 | 281 | 326 | 437 | 392 |
Earnings From Continuing Operations | 540 | 252 | 420 | 738 | 796 | 706 |
Minority Interest in Earnings | 14 | 13 | 32 | -30 | 16 | -52 |
Net Income | 554 | 265 | 452 | 708 | 812 | 654 |
Net Income to Common | 554 | 265 | 452 | 708 | 812 | 654 |
Net Income Growth | 400.50% | -41.37% | -36.16% | -12.81% | 24.16% | 115.13% |
Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 7 | 7 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 7 | 7 |
Shares Change | 0.25% | 0.08% | 1.52% | 20.11% | -0.01% | -0.03% |
EPS (Basic) | 68.31 | 32.69 | 55.81 | 88.75 | 122.26 | 98.52 |
EPS (Diluted) | 68.31 | 32.69 | 55.81 | 88.75 | 122.26 | 98.47 |
EPS Growth | 399.24% | -41.42% | -37.11% | -27.41% | 24.16% | 115.19% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 119 | -1,441 | 584 | 827 | 1,249 |
Free Cash Flow Per Share | - | 14.68 | -177.93 | 73.21 | 124.52 | 188.04 |
Dividend Per Share | 9.000 | 9.000 | 9.000 | 8.000 | 8.000 | 8.000 |
Dividend Growth | 0% | 0% | 12.50% | 0% | 0% | - |
Gross Margin | 30.81% | 29.20% | 24.88% | 25.93% | 34.05% | 26.98% |
Operating Margin | 14.92% | 12.82% | 7.95% | 8.52% | 16.72% | 13.84% |
Profit Margin | 4.25% | 2.10% | 4.24% | 7.39% | 10.00% | 7.28% |
Free Cash Flow Margin | - | 0.94% | -13.51% | 6.10% | 10.18% | 13.90% |
EBITDA | 2,498 | 2,162 | 1,345 | 1,254 | 1,758 | 1,585 |
EBITDA Margin | 19.17% | 17.12% | 12.61% | 13.10% | 21.65% | 17.64% |
D&A For EBITDA | 554.17 | 543 | 497 | 438 | 400 | 341 |
EBIT | 1,944 | 1,619 | 848 | 816 | 1,358 | 1,244 |
EBIT Margin | 14.92% | 12.82% | 7.95% | 8.52% | 16.72% | 13.84% |
Effective Tax Rate | 59.18% | 72.46% | 40.09% | 30.64% | 35.44% | 35.70% |